The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hykes Andrew since 2020.
This trader's CIK number is 1806431.
At the time of last reporting, Hykes Andrew was the President and CEO of Inari Medical, Inc.. (stock ticker symbol NARI).
Also see all insider trading activities at Inari Medical, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | NARI | 0 | $0 | 0 | $0 | 194,538 | $476,034 |
| 2024 | NARI | 0 | $0 | 21,000 | $1,084,695 | 0 | $0 |
| 2023 | NARI | 0 | $0 | 137,800 | $8,892,268 | 430,517 | $0 |
| 2022 | NARI | 0 | $0 | 69,000 | $5,603,361 | 10,000 | $4,280 |
| 2021 | NARI | 0 | $0 | 167,422 | $13,206,965 | 50,000 | $21,400 |
| 2020 | NARI | 5,650 | $107,350 | 54,800 | $3,786,926 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-10 | NARI | Option Ex | 194,538 | 2.45 | 476,034 |
| 2024-12-20 | NARI | Sale | 3,000 | 55.42 | 166,275 |
| 2024-11-20 | NARI | Sale | 3,000 | 50.83 | 152,490 |
| 2024-10-29 | NARI | Sale | 3,000 | 50.00 | 150,000 |
| 2024-08-20 | NARI | Sale | 3,000 | 50.00 | 150,000 |
| 2024-07-22 | NARI | Sale | 3,000 | 55.23 | 165,690 |
| 2024-07-01 | NARI | Sale | 3,000 | 50.08 | 150,240 |
| 2024-05-28 | NARI | Sale | 3,000 | 50.00 | 150,000 |
| 2023-11-16 | NARI | Sale | 37,448 | 59.87 | 2,241,824 |
| 2023-08-16 | NARI | Sale | 36,676 | 66.74 | 2,447,866 |
| 2023-05-16 | NARI | Sale | 17,916 | 70.87 | 1,269,706 |
| 2023-05-17 | NARI | Sale | 18,760 | 69.19 | 1,298,004 |
| 2023-03-20 | NARI | Sale | 9,000 | 64.45 | 580,095 |
| 2023-03-12 | NARI | Option Ex | 430,517 | .00 | 0 |
| 2023-02-21 | NARI | Sale | 9,000 | 55.19 | 496,710 |
| 2023-01-20 | NARI | Sale | 9,000 | 62.01 | 558,063 |
| 2022-10-20 | NARI | Sale | 9,000 | 72.63 | 653,652 |
| 2022-09-06 | NARI | Sale | 5,000 | 70.00 | 350,000 |
| 2022-08-01 | NARI | Sale | 5,000 | 78.47 | 392,350 |
| 2022-07-05 | NARI | Sale | 5,000 | 70.31 | 351,550 |
| 2022-06-07 | NARI | Sale | 5,000 | 70.08 | 350,390 |
| 2022-05-02 | NARI | Sale | 5,000 | 79.65 | 398,250 |
| 2022-04-01 | NARI | Sale | 10,000 | 91.22 | 912,159 |
| 2022-03-16 | NARI | Option Ex | 10,000 | .43 | 4,280 |
| 2022-02-28 | NARI | Sale | 6,304 | 90.05 | 567,675 |
| 2022-03-01 | NARI | Sale | 13,696 | 90.74 | 1,242,775 |
| 2022-01-18 | NARI | Sale | 5,000 | 76.91 | 384,560 |
| 2021-12-15 | NARI | Sale | 22,222 | .00 | 0 |
| 2021-10-19 | NARI | Sale | 9,000 | 87.49 | 787,419 |
| 2021-09-17 | NARI | Sale | 9,000 | 80.88 | 727,947 |
| 2021-08-18 | NARI | Option Ex | 20,000 | .43 | 8,560 |
| 2021-08-19 | NARI | Sale | 9,000 | 72.80 | 655,182 |
| 2021-07-19 | NARI | Sale | 9,000 | 85.28 | 767,538 |
| 2021-06-18 | NARI | Sale | 7,999 | 91.85 | 734,708 |
| 2021-06-21 | NARI | Sale | 1,001 | 91.41 | 91,504 |
| 2021-05-20 | NARI | Option Ex | 10,000 | .43 | 4,280 |
| 2021-05-19 | NARI | Sale | 9,000 | 82.58 | 743,210 |
| 2021-04-19 | NARI | Sale | 9,000 | 103.26 | 929,340 |
| 2021-03-19 | NARI | Sale | 9,000 | 109.30 | 983,682 |
| 2021-03-17 | NARI | Option Ex | 20,000 | .43 | 8,560 |
| 2021-02-19 | NARI | Sale | 9,000 | 117.44 | 1,056,942 |
| 2021-01-19 | NARI | Sale | 9,000 | 96.60 | 869,382 |
| 2021-01-13 | NARI | Sale | 27,600 | 95.66 | 2,640,105 |
| 2021-01-05 | NARI | Sale | 27,600 | 80.44 | 2,220,006 |
| 2020-12-18 | NARI | Sale | 27,400 | 70.84 | 1,940,961 |
| 2020-11-30 | NARI | Sale | 27,400 | 67.37 | 1,845,965 |
| 2020-05-27 | NARI | Buy | 5,650 | 19.00 | 107,350 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hykes Andrew (President and CEO of Inari Medical, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.